Douglas A. Levine, MD

  • Specialty: Gynecologic Oncology
  • Language: English
  • Phone: 646-501-4834

About Me

I am a board-certified gynecologic oncologist who specializes in the surgical treatment of women with known or suspected ovarian and endometrial cancers. For most women who have these gynecologic cancers, surgery is an important part of the initial treatment and increases the possibility of long-term success. Every time I enter the operating room, my entire focus and effort is directed toward completely removing the cancer.

A diagnosis of ovarian cancer can be very challenging for women and their families. Together, we create an individualized treatment plan that incorporates the latest knowledge in ovarian cancer therapy, both in the operating room and beyond. My teamwork approach to ovarian cancer therapy coupled with years of expertise allows my patients to benefit from the most advanced surgical and medical treatments.

In addition to my expertise in surgical management of advanced ovarian and endometrial cancers, I also have special training in minimally invasive surgery—laparoscopy and robotic surgery—and preventive surgery for selected patients. I incorporate chemotherapy that can be delivered directly into the abdomen for women who have advanced ovarian cancer. For women with recurrent ovarian cancer, I can use genomic testing to analyze tumors and develop individualized therapies. I use precision medicine to create better treatment options for all women who have ovarian cancer.

In my laboratory at NYU Langone, I focus on precision medicine, rare tumors, and early detection and prevention of gynecologic cancers. We are currently leading the development of national clinical trials for ovarian cancer prevention. We are also working to understand which women are most likely to respond to treatment with anticancer drugs so we can direct the best treatments toward the most appropriate patients. My research has been supported by the National Cancer Institute, the Department of Defense, Stand Up to Cancer, the Ovarian Cancer Research Fund, the Foundation for Women’s Cancer, the Entertainment Industry Foundation, and Cycle for Survival. 

I have authored or coauthored more than 160 peer-reviewed research papers, reviewed articles, and book chapters. I am the founding editor of Atlas of Procedures in Gynecologic Oncology, and I serve on the scientific advisory committee of the Ovarian Cancer Research Fund and the Clearity Foundation. I am also a special advisor to the board of directors of the Honorable Tina Brozman Foundation and the co-chair of the ovarian cancer, endometrial cancer, and uterine carcinosarcoma working groups for The Cancer Genome Atlas. I was honored to receive the Mentor Award from the American Congress of Obstetricians and Gynecologists in 2012 and the Foundation for Women’s Cancer’s Excellence in Ovarian Cancer Research Prize in 2013.

Conditions and Treatments

ovarian cancer, fallopian tube cancer, uterine cancer, cancer of endometrium, gynecologic cancer, ovarian cancer surgery, minimally invasive surgery, robotic surgery, ovarian cancer screening, cancer surgery, gynecological surgery, endometrial hyperplasia
Show More Conditions


  • Professor, Department of Obstetrics and Gynecology
  • Director, Division of Gynecologic Oncology
Board Certifications
  • American Board of Obstetrics & Gynecology (Gynecologic Oncology), 2007
  • American Board of Obstetrics & Gynecology - Obstetrics & Gynecology, 2005
Education and Training
  • Fellowship, Memorial Sloan Kettering Cancer Center, Gynecologic Oncology, 2004
  • Residency, Icahn School of Medicine at Mount Sinai, Obstetrics & Gynecology, 1999
  • MD from Mount Sinai School Of Medicine, 1995

Is this your profile?

Edit profile

Is this your profile?

Edit profile

Locations and Appointments

View Insurance Plans Accepted
  • Aetna
    • Aetna HMO
    • Aetna Indemnity
    • Aetna International
    • Aetna Medicare Managed Care
    • Aetna Meritain Health
    • Aetna Open Access Elect Choice (EPO)
    • Aetna Open Access HMO
    • Aetna POS
    • Aetna PPO
    • Aetna Student Health
    • Chesterfield Resources Inc
    • Christian Brothers Services
    • CoreSource
    • Nippon Life Of America - Aetna
    • Nippon Life-Aetna
    • Starmark
    • WellNet
  • Affinity
    • Affinity American Indian Exchange
    • Affinity Bronze Exchange
    • Affinity Catastrophic Exchange
    • Affinity Essential Plan 1
    • Affinity Essential Plan 2
    • Affinity Essential Plan 3
    • Affinity Essential Plan 4
    • Affinity Essential Platinum Exchange
    • Affinity Gold Exchange
    • Affinity HP Child Health Plus
    • Affinity HP Family Health Plus
    • Affinity HP Medicaid Managed Care
    • Affinity Medicaid Advantage
    • Affinity Medicare Managed Care
    • Affinity Medicare Solutions
    • Affinity Medicare Ultimate
    • Affinity Silver Exchange
  • Agewell
    • Agewell
  • BCBS GHI Composite
    • BCBS GHI Composite
  • BCBS Out of State
    • BCBS Out/State Medicare
    • BCBS Out/State EPO
    • BCBS Out/State HMO
    • BCBS Out/State Indemnity
    • BCBS Out/State POS
    • BCBS Out/State PPO
  • Beech
    • Beech Street PPO
    • Insurance Design Administrators
    • Professional Benefit Admin
  • Blue Cross Blue Shield
    • BCBS Bronze Guided Access Exchange
    • BCBS Bronze Guided Access HSA Exchange
    • BCBS Catastrophic Guided Access Exchange
    • BCBS EPO
    • BCBS Federal Program
    • BCBS Global Transplants
    • BCBS Gold Guided Access Exchange
    • BCBS HMO
    • BCBS Healthy New York
    • BCBS Indemnity
    • BCBS Mediblue Medicare HMO
    • BCBS Mediblue Medicare PPO
    • BCBS Open Access PPO (Hb Only)
    • BCBS POS
    • BCBS PPO
    • BCBS Pathway
    • BCBS Pathway Enhanced
    • BCBS Pathway X Enhanced
    • BCBS Silver Guided Access Exchange
    • BCBS Silver Guided Access HSA Exchange
    • Local 32BJ SEIU
    • Unicare
  • Carecore
    • CareCore Aetna
    • CareCore HIP Medicare
    • CareCore Health Net
    • CareCore Oxford
    • CareCore Oxford Medicare Advant
    • CareCore WellCare
  • Champva
    • Champva
  • Cigna
    • Cigna Behavioral Health
    • Cigna Great West PPO
    • Cigna HMO
    • Cigna Indemnity
    • Cigna Managed Care/POS
    • Cigna NALC
    • Cigna Open Access
    • Cigna Open Access PPO
    • Cigna PPO
    • Cigna Premier Plus
    • Great West HMO
    • MVP-Cigna Network
  • Elderplan
    • Elderplan
  • GEHA
    • GEHA
  • GHI
    • American Plan Administrators
    • American Plan Administrators - C/O H.D.A
    • GHI Emblem Health EPO
    • GHI Emblem Health PPO
    • GHI HMO
    • GHI HMO Medicare
    • GHI Medicare PPO
    • GHI Medicare Supplement
    • IUOE Local 14-14B
    • Wlny-TV Inc.
  • GHI Composite
    • GHI Composite
  • HIP
    • HIP Access I
    • HIP Access Ii
    • HIP Child Health Plus
    • HIP EPO
    • HIP HMO
    • HIP HMO (Healthcare Partners)
    • HIP Health Plan Of NY
    • HIP Medicare
    • HIP Medicare (Healthcare Partners)
    • HIP Montefiore
    • HIP Montefiore Medicare
    • HIP POS
    • HIP Smartstart
  • Health Republic
    • Health Republic Of NJ
  • Healthfirst
    • Health And Recovery Plan (Harp)
    • Health And Recovery Plan (Harp)- Nyu Risk
    • Healthfirst 65 Plus Plan (HMO)
    • Healthfirst 65- Nyu Risk
    • Healthfirst Absolute Care FIDA
    • Healthfirst Absolute Care FIDA- NYU Risk
    • Healthfirst Assured Care
    • Healthfirst Assured Care- NYU Risk
    • Healthfirst Bronze Leaf Exchange
    • Healthfirst Bronze Leaf Exchange- NYU Risk
    • Healthfirst Child Health Plus
    • Healthfirst Child Health Plus- NYU Risk
    • Healthfirst Complete Care
    • Healthfirst Complete Care- NYU Risk
    • Healthfirst Coordinated Benefits Plan (HMO)
    • Healthfirst Coordinated Benefits Plan- NYU Risk
    • Healthfirst Essential Plan 1
    • Healthfirst Essential Plan 1- NYU Risk
    • Healthfirst Essential Plan 2
    • Healthfirst Essential Plan 2- NYU Risk
    • Healthfirst Essential Plan 3
    • Healthfirst Essential Plan 3- NYU Risk
    • Healthfirst Essential Plan 4
    • Healthfirst Essential Plan 4- NYU Risk
    • Healthfirst Gold Leaf Exchange
    • Healthfirst Gold Leaf Exchange- NYU Risk
    • Healthfirst Green Leaf Exchange
    • Healthfirst Green Leaf Exchange- NYU Risk
    • Healthfirst Health New York- NYU Risk
    • Healthfirst Increased Benefits Plan
    • Healthfirst Increased Benefits Plan- NYU Risk
    • Healthfirst Life Improved Plan
    • Healthfirst Life Improved Plan- NYU Risk
    • Healthfirst Medicaid
    • Healthfirst Medicaid- NYU Risk
    • Healthfirst Personal Wellness Plan
    • Healthfirst Personal Wellness Plan- NYU Risk
    • Healthfirst Platinum Leaf Exchange
    • Healthfirst Platinum Leaf Exchange- NYU Risk
    • Healthfirst Senior Health Partners
    • Healthfirst Senior Health Partners- NYU Risk
    • Healthfirst Silver Leaf Exchange
    • Healthfirst Silver Leaf Exchange- NYU Risk
  • Humana
    • Humana Health Plan
  • Island Group Administration
    • Island Group Administration
  • Local 1199
    • Local 1199 NYU Member Choice
    • Local 1199 PPO
  • MVP Select Care Inc
    • MVP Preferred EPO
    • MVP Select Care Inc.
  • Magnacare
    • CDPHP
    • Cement & Concrete Workers District Council
    • Consolidated Health Plan
    • Independent Care Plus
    • Magnacare Direct Plus
    • Magnacare PPO
    • National Health Plan
  • Medicare
    • Medicare Part A
    • Medicare Part A and B
    • Medicare Part B
  • Multiplan
    • AXA Assistance USA
    • Administrative Concepts
    • Diversified Administration Corporation
    • Fiserv Health
    • Global Excel
    • Global Health
    • Guardian Life Insurance Co Of America
    • Health Net Of California
    • Humana Health Plan
    • Kaiser Foundation
    • Kaiser Permanente
    • Meritain Health
    • Multiplan - Capital Dist Phys Health
    • Multiplan PPO
    • Mutual Of Omaha
    • Nippon Life Ins Co-Multiplan
    • Nippon Life-Multiplan
    • PHCS
    • PHCS Director Guild
    • PHCS Healthcare (Champus)
    • PHCS Multiplan
    • PHCS Savility
    • Principal Financial
    • Principal Financial Group
    • Qualcare Inc
    • Screen Actors Guild - Producers
    • Teamsters Allied Benefits
    • US Life Insurance Company
  • Oxford
    • OptumHealth Behavioral Solutions
    • Oxford Health Plans Freedom
    • Oxford Health Plans Liberty
    • Oxford Optum Health
  • POMCO Insurance Company
    • POMCO Insurance Company
  • Qualcare Inc.
    • Qualcare Direct
  • Railroad Medicare
    • Palmetto GBA Railroad Medicare
  • Tricare
    • US Family Health Plan
  • United Healthcare
    • AARP Medicare Complete
    • NYS Health Insurance Plan NYSHIP
    • OptumHealth Behavioral Solutions
    • Oxford Health Plans Medicare Advantage
    • UHC AARP Medicare Complete Essential
    • UMR
    • United Health Care Options PPO (NYULMC Employees)
    • United Healthcare Choice
    • United Healthcare Choice (NYULMC Employees)
    • United Healthcare Choice NSLIJ
    • United Healthcare EPO
    • United Healthcare HMO
    • United Healthcare Inde
    • United Healthcare Medicare
    • United Healthcare Navigate
    • United Healthcare POS
    • United Healthcare PPO
    • United Healthcare Student Resources
  • Veterans Admin. Referral
    • Veterans Admin. Referral
  • Veterans Choice
    • Veterans Choice Program-VACAA
  • Vytra Healthcare
    • HIP Vytra Healthcare Managed Care
    • HIP Vytra Healthcare POS
    • HIP Vytra Healthcare PPO
  • Wellcare
    • WellCare Child Health Plus
    • WellCare Health Care Exchange Product
    • WellCare Medicaid Managed Care
    • WellCare Medicaid/Fhp
    • WellCare Medicare
    • Wellcare Essential Plan 1
NYU Langone Laura and Isaac Perlmutter Cancer Center

240 East 38th Street, 19th Floor
New York, NY 10016

Research My Research

Research Summary

My research is primarily focused on ovarian and endometrial cancers. The broad aim of this work is to develop novel biomarkers, expand the use of precision medicine, and understand rare tumors.

One particular area of interest is early detection and prevention of ovarian cancer. We are applying next generation sequencing to circulating and shed biomarkers in order to develop better approaches for primary, secondary, and tertiary ovarian cancer prevention. Primary prevention measures often involve surgical procedures, whereas secondary and tertiary prevention can capitalize on newly discovered biomarkers.

My colleagues and I are actively engaged in translational research that applies precision medicine to ongoing and completed clinical trials. We interrogate tumor specimens and companion normal tissue to determine what molecular features associate with patient responses in the context of an institutional or cooperative group clinical trial. We are also applying these techniques to model systems in order to identify patient subgroups that are uniquely sensitive or resistant to targeted therapies, such as PARP inhibitors or immune checkpoint blockade.

In recent years, my laboratory has discovered driver mutations for rare tumor types. We are elucidating the underlying mechanisms that permit these tumors to develop and spread. We are also developing biologic models for these rare tumors to help with drug development and to share with other scientists throughout the world so that collectively we can advance the fight against these rare tumors. 

As division director of gynecologic oncology, I have also overseen the development of our clinical trial portfolio and the translational research program.

Academic Contact

Academic office

240 East 38th Street

Nineteenth Floor

New York, NY 10016



Research Interests Timeline

These focus areas and their associated publications are derived from PubMed and the MeSH term library.
represents one publication


  • Quality of life among long-term survivors of advanced stage ovarian cancer: A cross-sectional approach

    Lutgendorf, Susan K; Shinn, Eileen; Carter, Jeanne; Leighton, Susan; Baggerly, Keith; Guindani, Michele; Fellman, Bryan; Matzo, Marianne; Slavich, George M; Goodman, Marc T; Tew, William; Lester, Jenny; Moore, Kathleen M; Karlan, Beth Y; Levine, Douglas A; Sood, Anil K Lutgendorf, Susan K; Shinn, Eileen; Carter, Jeanne; Leighton, Susan; Baggerly, Keith; Guindani, Michele; Fellman, Bryan; Matzo, Marianne; Slavich, George M; Goodman, Marc T; Tew, William; Lester, Jenny; Moore, Kathleen M; Karlan, Beth Y; Levine, Douglas A; Sood, Anil K
    Gynecologic oncology. 2017 Jul. 146 (1): 101-108

  • miR-200c-driven Mesenchymal-To-Epithelial Transition is a Therapeutic Target in Uterine Carcinosarcomas

    Tseng, Jill H; Bisogna, Maria; Hoang, Lien N; Olvera, Narciso; Rodriguez-Aguayo, Cristian; Lopez-Berestein, Gabriel; Sood, Anil K; Levine, Douglas A; Jelinic, Petar Tseng, Jill H; Bisogna, Maria; Hoang, Lien N; Olvera, Narciso; Rodriguez-Aguayo, Cristian; Lopez-Berestein, Gabriel; Sood, Anil K; Levine, Douglas A; Jelinic, Petar
    Scientific reports. 2017 Jun 15. 7 (1): 3614-3614

  • Treatment with carboplatin and taxane chemotherapy increases T-cell receptor (TCR) clonality in high-grade serous ovarian cancer (HGSOC) [Meeting Abstract]

    LaVigne, K; Cybulska, P; Walther, T; Emerson, R O; Vignali, M; Park, K J; Levine, D A; Chi, D S; Zivanovic, O; Snyder, Charen A E LaVigne, K; Cybulska, P; Walther, T; Emerson, R O; Vignali, M; Park, K J; Levine, D A; Chi, D S; Zivanovic, O; Snyder, Charen A E
    Gynecologic oncology. 2017 June. Conference: (48th): 20-21

Read All Publications (214)